Research output per year
Research output per year
Personal profile
Research interests
My primary clinical research focus is the implementation of novel analytical methodologies to improve treatment decision-making in patients with cancer.
Clinical interests
Immunotherapy clinical trials, primary brain tumors and brain metastases, melanoma, merkel cell carcinoma.
Fingerprint
Dive into the research topics where Tanner Johanns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma
Damato, A. R., Katumba, R. G. N., Luo, J., Atluri, H., Talcott, G. R., Govindan, A., Slat, E. A., Weilbaecher, K. N., Tao, Y., Huang, J., Butt, O. H., Ansstas, G., Johanns, T. M., Chheda, M. G., Herzog, E. D., Rubin, J. & Campian, J., May 1 2022, In: Neuro-Oncology Practice. 9, 3, p. 193-200 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
Schaettler, M. O., Richters, M. M., Wang, A. Z., Skidmore, Z. L., Fisk, B., Miller, K. E., Vickery, T. L., Kim, A. H., Chicoine, M. R., Osbun, J. W., Leuthardt, E. C., Dowling, J. L., Zipfel, G. J., Dacey, R. G., Lu, H. C., Johanns, T. M., Griffith, O. L., Mardis, E. R., Griffith, M. & Dunn, G. P., Jan 2022, In: Cancer discovery. 12, 1, p. 154-171 18 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Considerations for personalized neoantigen vaccination in Malignant glioma
Dunn, G. P., Sherpa, N., Manyanga, J. & Johanns, T. M., Jul 2022, In: Advanced Drug Delivery Reviews. 186, 114312.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Erratum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma(Neuro-Oncology Advances DOI: 10.1093/noajnl/vdab164)
Butt, O. H., Zhou, A. Y., Huang, J., Leidig, W. A., Silberstein, A. E., Chheda, M. G., Johanns, T. M., Ansstas, G., Liu, J., Talcott, G., Nakiwala, R., Shimony, J. S., Kim, A., Leuthardt, E. C., Tran, D. D. & Campian, J., Jan 1 2022, In: Neuro-Oncology Advances. 4, 1, vdac042.Research output: Contribution to journal › Comment/debate
Open Access -
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma
Butt, O. H., Zhou, A., Huang, J., Leidig, W. A., Silberstein, A. E., Chheda, M. G., Johanns, T. M., Ansstas, G., Liu, J., Talcott, G., Nakiwala, R., Shimony, J. S., Kim, A., Leuthardt, E. C., Tran, D. D. & Campian, J., Jan 1 2021, In: Neuro-Oncology Advances. 3, 1, vdab164.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations